QxP Pharma Consultant & GMP Services

Capacity calculation in pharma manufacturing tells you the maximum output your plant can deliver with its current machines, people and available time. Get it wrong and you either miss customer deadlines or leave costly equipment idle. Get it right and you can quote lead times with confidence, plan batches properly and justify new investments. This guide covers the production capacity formula , a worked tablet-compression example, four calculation methods, pharma-specific constraints, and practical ways to increase output without buying new machines. It is written for plant heads, planners and project owners in regulated manufacturing. Quick Takeaways Capacity = Available time × Number of machines × Output per minute. Choose one time base and use it across every department. Track capacity utilization to reveal hidden losses. Improve OEE, changeovers and maintenance before adding shifts or machines What Is Production Capacity? Production capacity is the maximum quantity a ...

A project report is a written plan that explains your business idea in facts and numbers. It shows what you will build, what it will cost, and how it will earn. For a drug manufacturing unit, the report goes further: it must also cover GMP layout, utilities, equipment, and regulatory approvals. That is why a detailed project report (DPR) is the first serious step of any pharma plant. In short: A good pharma project report = realistic numbers + GMP-compliant design + a clear regulatory roadmap. Banks and regulators reject reports that miss any of the three. What Is a Project Report in Pharma? Banks, investors, and government bodies read your project report before they commit money or approvals. In pharma, they also check whether your plant plan can meet Schedule M, WHO-GMP, and CDSCO expectations. A report that treats a pharma plant like any other factory will not pass this check. Types of Project Reports Preliminary report: a quick check on whether your idea can work...

Audit compliance protects your licence, your customers and your brand. One missing control can mean a fine, a failed inspection or a lost contract. For pharma manufacturers the stakes are higher, because regulators such as CDSCO and USFDA can inspect a plant with little warning. This guide explains how audit compliance works, which audits you may face, and how to prepare with confidence. What Is a Compliance Audit? A compliance audit is a structured review of what a company does and the records it keeps. It confirms that the business follows its own policies, the law and the standards of its industry. Auditors check documents, talk to employees and watch daily operations. They then report gaps and recommend fixes. Audits can cover data security, personal data protection, financial reporting, workplace safety and product quality. In the pharmaceutical industry they also cover manufacturing practices, record keeping and data integrity. Most companies run audits as part of...

In today's pharmaceutical manufacturing environment, having a technically sound facility is only half the equation. Regulators now expect proof that the people running that facility actually understand — and can demonstrate — Good Practice principles. This is where GxP training stops being a checkbox exercise and becomes a core part of audit readiness, documentation discipline, and overall quality culture. QxP Pharma & GMP Service offers hands-on GxP training programs built to give pharmaceutical teams real, practical understanding — not just theoretical awareness — of what regulators expect on the floor. What Makes QxP Pharma's Training Approach Different Most training vendors hand over a standard slide deck and move on. QxP takes a different route. Established in 2018 and headquartered in South Bopal, Ahmedabad, the team has worked across more than 300 turnkey projects and GMP compliance engagements — meaning the training content is drawn from actual audit find...

Launching a new pharmaceutical product in India is rarely just a formulation problem. In practice, it's a facility-planning, documentation, and regulatory-sequencing problem that happens to involve chemistry along the way. Get the New Product Development Procedure For Pharma wrong at the planning stage, and you'll spend the next several months firefighting stability failures, layout mismatches, or a Schedule M query that could have been resolved before ground was even broken. QxP Pharma Project & GMP Services , operating out of Ahmedabad since 2018, has worked through this process across 300+ turnkey and GMP compliance projects in India. What follows isn't the textbook version of new product development — it's the practical version, shaped by what actually goes wrong on real projects and how to prevent it before it becomes expensive. What Documents Does Pharma Product Development Actually Require? Before getting into process, it helps to understand what you...

Setting up or running a pharmaceutical plant in India comes with a long checklist — machinery, cleanrooms, licensing, workforce training. But the one factor that quietly decides whether a plant sails through inspections or gets stuck in endless observation cycles is its Quality Management System (QMS) . Why QMS Is the Real Backbone of Plant Quality It's a pattern seen across the industry: a plant invests heavily in top-tier equipment and infrastructure, yet still struggles during CDSCO or State FDA inspections. The reason usually isn't the machinery — it's a QMS that's weak, reactive, or disconnected from actual shop-floor practices. A properly implemented QMS improves batch-to-batch consistency, reduces deviations, accelerates regulatory approvals, and ultimately protects patient safety. What a Strong QMS Actually Covers SOP architecture that QA teams can realistically maintain without drowning in constant revisions Deviation and CAPA management , with genuine r...